In a recent transaction, Matthew Thompson, associated with Vivos Therapeutics, Inc. [VVOS], executed a stock transaction on June 20, 2024. The specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed. This event may be of interest to investors who follow Vivos Therapeutics, as insider transactions can provide insights into the company's financial health and future prospects.

In a recent transaction, Matthew Thompson, associated with Vivos Therapeutics, Inc. [VVOS], executed a stock transaction on June 20, 2024. The specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed. This event may be of interest to investors who follow Vivos Therapeutics, as insider transactions can provide insights into the company's financial health and future prospects.